STAT6 and asthma: TMC-264 was originally discovered for its potent, selective inhibitory affect against tyrosine phosphorylation of the transcription factor STAT6 (Sakurai et al. 2003b), a small molecule target for asthma pathogenesis (Hebenstreit et al. 2006).